The research peptide market has a trust problem. For years, researchers have had to choose between suppliers offering vague purity claims, inconsistent batch quality, and certificates of analysis that raise more questions than they answer. We lived that frustration firsthand.

Peptari was founded to address the quality and transparency gaps that plague the peptide supply chain. We saw researchers waste weeks troubleshooting experiments, only to discover the compound itself was the variable. We saw testing documentation that obscured methodology instead of revealing it. We saw suppliers who treated accountability as optional.